BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25806791)

  • 1. Activation of HIFa pathway in mature osteoblasts disrupts the integrity of the osteocyte/canalicular network.
    Zuo GL; Zhang LF; Qi J; Kang H; Jia P; Chen H; Shen X; Guo L; Zhou HB; Wang JS; Zhou Q; Qian ND; Deng LF
    PLoS One; 2015; 10(3):e0121266. PubMed ID: 25806791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss.
    Zhao Q; Shen X; Zhang W; Zhu G; Qi J; Deng L
    Bone; 2012 Mar; 50(3):763-70. PubMed ID: 22193550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of hypoxia inducible factor-1alpha on osteoblast function in osteogenesis].
    Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3357-61. PubMed ID: 18478952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.
    Wang Y; Wan C; Deng L; Liu X; Cao X; Gilbert SR; Bouxsein ML; Faugere MC; Guldberg RE; Gerstenfeld LC; Haase VH; Johnson RS; Schipani E; Clemens TL
    J Clin Invest; 2007 Jun; 117(6):1616-26. PubMed ID: 17549257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vhl deficiency in osteocytes produces high bone mass and hematopoietic defects.
    Loots GG; Robling AG; Chang JC; Murugesh DK; Bajwa J; Carlisle C; Manilay JO; Wong A; Yellowley CE; Genetos DC
    Bone; 2018 Nov; 116():307-314. PubMed ID: 30172741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblast-secreted factors promote proliferation and osteogenic differentiation of bone marrow stromal cells via VEGF/heme-oxygenase-1 pathway.
    Zhang LF; Qi J; Zuo G; Jia P; Shen X; Shao J; Kang H; Yang H; Deng L
    PLoS One; 2014; 9(6):e99946. PubMed ID: 24940620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen sensing and osteogenesis.
    Wang Y; Wan C; Gilbert SR; Clemens TL
    Ann N Y Acad Sci; 2007 Nov; 1117():1-11. PubMed ID: 18056033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of VHL in mesenchymal progenitors of the limb bud alters multiple steps of endochondral bone development.
    Mangiavini L; Merceron C; Araldi E; Khatri R; Gerard-O'Riley R; Wilson TL; Rankin EB; Giaccia AJ; Schipani E
    Dev Biol; 2014 Sep; 393(1):124-36. PubMed ID: 24972088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration.
    Wan C; Gilbert SR; Wang Y; Cao X; Shen X; Ramaswamy G; Jacobsen KA; Alaql ZS; Eberhardt AW; Gerstenfeld LC; Einhorn TA; Deng L; Clemens TL
    Proc Natl Acad Sci U S A; 2008 Jan; 105(2):686-91. PubMed ID: 18184809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice.
    Weng T; Xie Y; Huang J; Luo F; Yi L; He Q; Chen D; Chen L
    J Bone Miner Res; 2014 Apr; 29(4):820-9. PubMed ID: 23999831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA; Ashcroft M
    Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein.
    Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C
    Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α facilitates osteocyte-mediated osteoclastogenesis by activating JAK2/STAT3 pathway in vitro.
    Zhu J; Tang Y; Wu Q; Ji YC; Feng ZF; Kang FW
    J Cell Physiol; 2019 Nov; 234(11):21182-21192. PubMed ID: 31032948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Hippel-Lindau Protein Is Required for Optimal Alveolar Macrophage Terminal Differentiation, Self-Renewal, and Function.
    Izquierdo HM; Brandi P; Gómez MJ; Conde-Garrosa R; Priego E; Enamorado M; Martínez-Cano S; Sánchez I; Conejero L; Jimenez-Carretero D; Martín-Puig S; Guilliams M; Sancho D
    Cell Rep; 2018 Aug; 24(7):1738-1746. PubMed ID: 30110631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
    Heino TJ; Hentunen TA; Väänänen HK
    Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.
    Wang J; Ma Y; Jiang H; Zhu H; Liu L; Sun B; Pan S; Krissansen GW; Sun X
    J Hepatol; 2011 Aug; 55(2):359-68. PubMed ID: 21168458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway.
    Liu T; Zhao L; Chen W; Li Z; Hou H; Ding L; Li X
    Int J Mol Med; 2014 May; 33(5):1236-42. PubMed ID: 24549370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO.
    Rankin EB; Wu C; Khatri R; Wilson TL; Andersen R; Araldi E; Rankin AL; Yuan J; Kuo CJ; Schipani E; Giaccia AJ
    Cell; 2012 Mar; 149(1):63-74. PubMed ID: 22464323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.